Aveanna Healthcare Holdings Pre-Tax Income 2020-2024 | AVAH

Aveanna Healthcare Holdings pre-tax income from 2020 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
Aveanna Healthcare Holdings Annual Pre-Tax Income
(Millions of US $)
2023 $-139
2022 $-664
2021 $-114
2020 $-52
2019 $-75
Aveanna Healthcare Holdings Quarterly Pre-Tax Income
(Millions of US $)
2024-06-30 $4
2024-03-31 $1
2023-12-31 $-32
2023-09-30 $-102
2023-06-30 $25
2023-03-31 $-30
2022-12-31 $-239
2022-09-30 $22
2022-06-30 $-474
2022-03-31 $28
2021-12-31 $-122
2021-09-30 $1
2021-06-30 $1
2021-03-31 $6
2020-12-31 $-7
2020-09-30 $-8
2020-06-30 $-75
2020-03-31 $39
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.127B $1.895B
Aveanna Healthcare Holdings Inc. is a diversified home care platform focused on providing care to medically complex, high-cost patient populations. Aveanna Healthcare Holdings Inc. is based in Atlanta, Georgia.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.419B 12.35
Quest Diagnostics (DGX) United States $17.788B 18.03
DaVita (DVA) United States $12.272B 15.87
Encompass Health (EHC) United States $10.397B 24.51
Chemed (CHE) United States $8.402B 25.82
Elanco Animal Health (ELAN) United States $6.955B 16.55
RadNet (RDNT) United States $5.364B 127.25
Option Care Health (OPCH) United States $3.826B 18.13
Amedisys (AMED) United States $3.166B 22.54
LifeStance Health (LFST) United States $2.816B 0.00
Addus HomeCare (ADUS) United States $2.313B 27.14
Astrana Health (ASTH) United States $2.305B 36.12
U.S Physical Therapy (USPH) United States $1.434B 37.73
Pennant (PNTG) United States $1.148B 46.42
Atai Life Sciences (ATAI) Germany $0.237B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00